Women with breast cancer exhibited higher risk for heart failure, cardiomyopathy and other cardiovascular disease events than women without breast cancer, according to prospective study results published in Journal of Clinical Oncology.
Researchers also reported higher rates of cardiovascular disease-related mortality and all-cause mortality in the breast cancer cohort.
Risks varied according to the type of cancer treatment women received.
“The most important take-home message here is that women who receive anthracycline and/or trastuzumab-based chemotherapy, radiation therapy and